Name: UMIN ID:
Unique ID issued by UMIN | UMIN000041389 |
---|---|
Receipt number | R000046988 |
Scientific Title | A 2-year study comparing the efficacy and safety of anti-VEGF drugs (aflibercept and brolucizumab) in patients with exudative age-related macular degeneration. |
Date of disclosure of the study information | 2020/08/12 |
Last modified on | 2020/09/28 22:04:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/08/11 17:12:49 | ||
2 | Update | 2020/09/28 22:03:47 | Primary outcomes Primary outcomes |
|
3 | Update | 2020/09/28 22:04:22 | Target sample size |